3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
19
Colonic Neoplasms
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Large B-Cell, Diffuse
4
Cholangiocarcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Endometrial Neoplasms
3
Adenocarcinoma
3
Recurrence
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Prostatic Neoplasms
1
Interventions
Cyclophosphamide
4
Etoposide
2
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Doxorubicin
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.